Rhoneil Pena

NKTR-214, an Engineered Cytokine with Biased IL2 Receptor Binding, Increased Tumor Exposure, and Marked Efficacy in Mouse Tumor Models

Deborah H. Charych, Ute Hoch, John L. Langowski et al. · Clinical Cancer Research · 2016 · 392 citations

Life Sciences, Immunology, Oncology +17

NKTR-255, a novel polymer-conjugated rhIL-15 with potent antitumor efficacy

Takahiro Miyazaki, Mekhala Maiti, Marlene Hennessy et al. · Journal for ImmunoTherapy of Cancer · 2021 · 53 citations · Full text

Medicine, Immunology, Pharmacology +17

Bempegaldesleukin (<scp>BEMPEG</scp>; <scp>NKTR</scp>‐214) efficacy as a single agent and in combination with checkpoint‐inhibitor therapy in mouse models of osteosarcoma

Marlene Hennessy, Andrew Wahba, Kumar Felix et al. · International Journal of Cancer · 2020 · 20 citations · Full text

Medicine, Oncology, Pharmacology +17

Abstract 3755: Comprehensive antitumor immune activation by a novel TLR7/8 targeting agent NKTR-262 combined with CD122-biased immunostimulatory cytokine NKTR-214

Saul Kivimäe, Marlene Hennessy, Rhoneil Pena et al. · Cancer Research · 2018 · 19 citations

Life Sciences, Immunology, Pharmacology +17

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two

Casey R. Ager, Matthew J. Reilley, Courtney Nicholas et al. · Journal for ImmunoTherapy of Cancer · 2016 · 17 citations · Full text

Medicine, Immunology, Oncology +17